NEWS

I-SPY 2 DESIGNER DESCRIBES PROGRAM'S MANY INNOVATIONS

Donald A. Berry, PhD, is a leader in the development of innovative statistical methodology for the improvement of clinical trial design and analysis, especially the Bayesian methods used in the I-SPY program. His research deals with the theory and application of statistics, with relevance in all areas of health research. As founding head of the Division of Quantitative Sciences at The University of Texas MD Anderson Cancer, Berry has overseen the design of more than 300 clinical trials.

Click to Read More